Stocks turn higher as investors await more earnings results, inflation data

Wall Street’s key benchmarks crept upward Tuesday after U.S. stocks started the week lower in a choppy session wrought by mixed corporate earnings and renewed Federal Reserve worries ahead of…

Aim Strong Growth in Business Results and Actively Deliver Returns to Shareholders

CNOOC Limited Announces its 2022 Business Strategy and Development Plan HONG KONG, Jan. 11, 2022 /PRNewswire/ — CNOOC Limited (the “Company“, SEHK: 00883) today announces a summary of its business…

How to Change Google Search Results Explained by Australian

Sydney, Jan. 04, 2022 (GLOBE NEWSWIRE) — E-Web Marketing, a management agency based in Chatswood, NSW, Australia, has identified a way to update search results for keywords. The process that…

Puxin Limited Announces Second Quarter 2021 Unaudited Financial Results

BEIJING, Dec. 29, 2021 /PRNewswire/ — Puxin Limited (NYSE: NEW) (“Puxin” or the “Company”), a private educational services provider in China, today announced its unaudited financial results for the second…

BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update

JERUSALEM, Nov. 30, 2021 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other…

My Success Pros (Success Pros LLC) Releases Data-Driven Education and Business Services for Client Learning to Achieve the Best Results

My Success Pros, an accomplished business consulting provider, uses a methodology developed through experience and backed by science to achieve the best results for their clients. My Success Pros My…

BiomX Reports Third Quarter 2021 Financial Results and Provides Business Update

Announces Strategic Focus on Cystic Fibrosis and Atopic Dermatitis Programs Based on Potential Proof-of-Concept Clinical Data Readouts in 2022 Cash Runway Now Extended to End of 2023, Well Beyond Key…

9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021

– Phase 2 vurolenatide VIBRANT study enrollment anticipated to be completed before year-end; topline results for short bowel syndrome expected in Q1 2022 –– Larazotide Phase 3 for celiac disease…

IDEAYA Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

– Strong balance sheet of ~$386 million cash, cash equivalents and marketable securities is anticipated to fund planned operations into 2025 – Observed IDE397 preliminary clinical activity in early Phase…

Newtek Business Services Corp. Reports Full Year 2021 Financial Results

Newtek Business Services Corp. Achieves Record SBA 7(a) Loan Fundings of $198.0 Million in the Fourth Quarter and $560.6 Million for the Full Year 2021 BOCA RATON, Fla., Feb. 23,…